US5807715A
(en)
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
US5169939A
(en)
|
1985-05-21 |
1992-12-08 |
Massachusetts Institute Of Technology & Pres. & Fellows Of Harvard College |
Chimeric antibodies
|
US4720449A
(en)
|
1985-06-03 |
1988-01-19 |
Polaroid Corporation |
Thermal imaging method
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
WO1991000906A1
(en)
|
1989-07-12 |
1991-01-24 |
Genetics Institute, Inc. |
Chimeric and transgenic animals capable of producing human antibodies
|
US6713610B1
(en)
|
1990-01-12 |
2004-03-30 |
Raju Kucherlapati |
Human antibodies derived from immunized xenomice
|
US6673986B1
(en)
|
1990-01-12 |
2004-01-06 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
US6657103B1
(en)
|
1990-01-12 |
2003-12-02 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
AU633698B2
(en)
|
1990-01-12 |
1993-02-04 |
Amgen Fremont Inc. |
Generation of xenogeneic antibodies
|
US7041871B1
(en)
|
1995-10-10 |
2006-05-09 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
US5770429A
(en)
*
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US6255458B1
(en)
|
1990-08-29 |
2001-07-03 |
Genpharm International |
High affinity human antibodies and human antibodies against digoxin
|
WO1992003918A1
(en)
|
1990-08-29 |
1992-03-19 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
US7084260B1
(en)
|
1996-10-10 |
2006-08-01 |
Genpharm International, Inc. |
High affinity human antibodies and human antibodies against human antigens
|
US6300129B1
(en)
|
1990-08-29 |
2001-10-09 |
Genpharm International |
Transgenic non-human animals for producing heterologous antibodies
|
WO1993004169A1
(en)
|
1991-08-20 |
1993-03-04 |
Genpharm International, Inc. |
Gene targeting in animal cells using isogenic dna constructs
|
EP0746609A4
(en)
|
1991-12-17 |
1997-12-17 |
Genpharm Int |
Transgenic non-human animals capable of producing heterologous antibodies
|
NZ255101A
(en)
|
1992-07-24 |
1997-08-22 |
Cell Genesys Inc |
A yeast artificial chromosome (yac) vector containing an hprt minigene expressible in murine stem cells and genetically modified rodent therefor
|
DE4228162C1
(en)
|
1992-08-25 |
1994-01-13 |
Rajewsky Klaus Dr |
Method for replacing homologous gene segments from mammals in the germline of non-human mammals
|
US5565321A
(en)
|
1993-01-22 |
1996-10-15 |
Immunex Corporation |
Detection of mutations in a CD40 ligand gene
|
EP0754225A4
(en)
|
1993-04-26 |
2001-01-31 |
Genpharm Int |
Transgenic non-human animals capable of producing heterologous antibodies
|
DE4331162A1
(en)
|
1993-09-14 |
1995-03-16 |
Bayer Ag |
Process for the preparation of cyanine dyes
|
BE1007904A3
(en)
|
1993-12-23 |
1995-11-14 |
Dsm Nv |
Process for the preparation of an alkanol AND / OR alkanone.
|
US7119248B1
(en)
|
1994-04-12 |
2006-10-10 |
Miltenyi Biotec Gmbh |
Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof
|
US6130364A
(en)
|
1995-03-29 |
2000-10-10 |
Abgenix, Inc. |
Production of antibodies using Cre-mediated site-specific recombination
|
AU3507297A
(en)
|
1996-06-26 |
1998-01-14 |
Baylor College Of Medicine |
Chromosomal rearrangement by insertion of two recombination substrates
|
ES2294799T3
(en)
|
1996-06-27 |
2008-04-01 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. |
MOLECULES OF ANTIBODIES THAT SPECIFICALLY INTERACT WITH THE ACTIVE SITE OR HIDIDURA OF A DIANA MOLECULA.
|
CA2616914C
(en)
|
1996-12-03 |
2012-05-29 |
Abgenix, Inc. |
Egfr-binding antibody
|
US6319906B1
(en)
|
1996-12-31 |
2001-11-20 |
Isis Pharmaceuticals |
Oligonucleotide compositions and methods for the modulation of the expression of B7 protein
|
DE19742706B4
(en)
|
1997-09-26 |
2013-07-25 |
Pieris Proteolab Ag |
lipocalin muteins
|
DK1034262T3
(en)
|
1997-11-18 |
2005-11-28 |
Pioneer Hi Bred Int |
Compositions and Methods for Genetic Modification of Plants
|
EP0939120A1
(en)
|
1998-02-27 |
1999-09-01 |
Gesellschaft für biotechnologische Forschung mbH (GBF) |
Method for marker-free repetitive DNA expression cassette exchange in the genome of cells or parts of cells
|
GB9823930D0
(en)
|
1998-11-03 |
1998-12-30 |
Babraham Inst |
Murine expression of human ig\ locus
|
IL127127A0
(en)
|
1998-11-18 |
1999-09-22 |
Peptor Ltd |
Small functional units of antibody heavy chain variable regions
|
US6818418B1
(en)
|
1998-12-10 |
2004-11-16 |
Compound Therapeutics, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
US7115396B2
(en)
|
1998-12-10 |
2006-10-03 |
Compound Therapeutics, Inc. |
Protein scaffolds for antibody mimics and other binding proteins
|
US6914128B1
(en)
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
AU5867100A
(en)
|
1999-05-03 |
2000-12-12 |
Medarex, Inc. |
Human antibodies to staphylococcus aureus
|
US6833268B1
(en)
|
1999-06-10 |
2004-12-21 |
Abgenix, Inc. |
Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
|
US7605238B2
(en)
|
1999-08-24 |
2009-10-20 |
Medarex, Inc. |
Human CTLA-4 antibodies and their uses
|
CA2307503A1
(en)
|
2000-05-02 |
2001-11-02 |
Carlos F. Barbas Iii |
Peptides for use as a vaccine or treatment for hiv infection
|
DE60137421D1
(en)
|
2000-06-29 |
2009-03-05 |
Abbott Lab |
ANTIBODIES WITH TWO SPECIFICITIES AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
CA2410551A1
(en)
*
|
2000-06-30 |
2002-01-10 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw (Vib) |
Heterodimeric fusion proteins
|
CN1455817A
(en)
|
2000-07-21 |
2003-11-12 |
(由农业部部长代表的)美利坚合众国 |
Methods for replacement, translocation and stacking of DNA in eukaryotic genomes
|
CA2421447C
(en)
|
2000-09-08 |
2012-05-08 |
Universitat Zurich |
Collections of repeat proteins comprising repeat modules
|
US6586251B2
(en)
|
2000-10-31 |
2003-07-01 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
US7105348B2
(en)
|
2000-10-31 |
2006-09-12 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
NZ525664A
(en)
|
2000-11-17 |
2008-08-29 |
Kirin Holdings Kk |
Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
|
ES2405944T3
(en)
|
2000-11-30 |
2013-06-04 |
Medarex, Inc. |
Nucleic acids encoding reorganized human immunoglobulin sequences from transgenic transchromosomal mice
zadas
|
DK1409646T3
(en)
|
2000-12-19 |
2012-08-06 |
Altor Bioscience Corp |
Transgenic animals comprising a humanized immune system
|
DZ3494A1
(en)
|
2001-01-05 |
2002-07-11 |
Pfizer |
INSULIN ANALOGUE GROWTH FACTOR ANTI-RECEPTOR ANTIBODIES
|
GB0110029D0
(en)
|
2001-04-24 |
2001-06-13 |
Grosveld Frank |
Transgenic animal
|
GB0115256D0
(en)
|
2001-06-21 |
2001-08-15 |
Babraham Inst |
Mouse light chain locus
|
FR2827302B1
(en)
|
2001-07-13 |
2003-10-10 |
Genoway |
TRANSGENIC CELL AND ANIMAL MODELING HUMAN ANTIGENIC PRESENTATION AND USES THEREOF
|
AU2002319544B2
(en)
|
2001-08-10 |
2008-07-10 |
Aberdeen University |
Antigen binding domains from fish
|
WO2003031656A1
(en)
|
2001-10-05 |
2003-04-17 |
United States Environmental Protection Agency |
Genetic testing for male factor infertility
|
US20060199204A1
(en)
|
2001-10-05 |
2006-09-07 |
U.S. Epa |
Genetic testing for male factor infertility
|
DE60127143T2
(en)
|
2001-11-14 |
2007-11-15 |
Affimed Therapeutics Ag |
Bispecific antibodies against CD19 and CD16 and their use
|
US7435871B2
(en)
|
2001-11-30 |
2008-10-14 |
Amgen Fremont Inc. |
Transgenic animals bearing human Igλ light chain genes
|
AU2003214842A1
(en)
|
2002-01-17 |
2003-09-02 |
Albert Einstein College Of Medicine Of Yeshiva University |
Mutations caused by activation-induced cytidine deaminase
|
US8877901B2
(en)
|
2002-12-13 |
2014-11-04 |
Immunomedics, Inc. |
Camptothecin-binding moiety conjugates
|
CA2872136C
(en)
|
2002-07-18 |
2017-06-20 |
Merus B.V. |
Recombinant production of mixtures of antibodies
|
US20040128703A1
(en)
|
2002-09-09 |
2004-07-01 |
Hiroaki Shizuya |
Methods and compositions for the generation of humanized mice
|
ES2559763T3
(en)
|
2002-09-10 |
2016-02-15 |
Affimed Gmbh |
CD3 specific human antibody with immunosuppressive properties
|
US7700356B2
(en)
|
2002-11-08 |
2010-04-20 |
The United States Of America As Represented By The Secretary Of Agriculture |
System for gene targeting and producing stable genomic transgene insertions
|
DE10251918A1
(en)
|
2002-11-08 |
2004-05-19 |
Horn, Carsten, Dipl.-Biochem. Dr. |
Inheritable integration of DNA into germ-line invertebrate cells, useful for large-scale production of transgenic insects, includes post-transformational removal of mobilizable elements to increase stability
|
CL2003002461A1
(en)
|
2002-11-27 |
2005-01-07 |
Dow Chemical Company Agroscien |
IMMUNOGLOBULIN THAT UNDERSTANDS AT LEAST ONE AFUCOSILATED GLICAN, COMPOSITION THAT CONTAINS IT, NUCLEOTIDIC SEQUENCE AND VECTOR THAT UNDERSTANDS IT, PROCEDURE TO PRODUCE IMMUNOGLOBULIN SAID IN PLANTS.
|
CA2512647C
(en)
|
2003-01-07 |
2013-10-08 |
Symphogen A/S |
Method for manufacturing recombinant polyclonal proteins
|
GB2398784B
(en)
|
2003-02-26 |
2005-07-27 |
Babraham Inst |
Removal and modification of the immunoglobulin constant region gene cluster of a non-human mammal
|
US20100069614A1
(en)
|
2008-06-27 |
2010-03-18 |
Merus B.V. |
Antibody producing non-human mammals
|
AU2004242846A1
(en)
|
2003-05-31 |
2004-12-09 |
Micromet Ag |
Pharmaceutical compositions comprising bispecific anti-CD3, anti-CD19 antibody constructs for the treatment of B-cell related disorders
|
WO2005001087A2
(en)
|
2003-06-11 |
2005-01-06 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying genes in eukaryotic cells
|
GB2403475B
(en)
|
2003-07-01 |
2008-02-06 |
Oxitec Ltd |
Stable integrands
|
JP4871126B2
(en)
|
2003-07-04 |
2012-02-08 |
アフィボディ・アーベー |
Polypeptide having binding affinity for HER2
|
US7663017B2
(en)
|
2003-07-30 |
2010-02-16 |
Institut Pasteur |
Transgenic mice having a human major histocompatability complex (MHC) phenotype, experimental uses and applications
|
US20050153392A1
(en)
|
2003-08-11 |
2005-07-14 |
Roland Buelow |
Transgenesis with humanized immunoglobulin loci
|
AU2003275958A1
(en)
|
2003-08-25 |
2005-03-10 |
Pieris Proteolab Ag |
Muteins of tear lipocalin
|
US7604994B2
(en)
*
|
2003-09-03 |
2009-10-20 |
Morphotek, Inc. |
Genetically altered antibody-producing cell lines with improved antibody characteristics
|
CA2445602C
(en)
|
2003-10-20 |
2014-01-14 |
Campusgen Gmbh |
Nucleotide sequence for creatinine deiminase and method of use
|
SG149004A1
(en)
|
2003-12-05 |
2009-01-29 |
Bristol Myers Squibb Co |
Inhibitors of type 2 vascular endothelial growth factor receptors
|
KR101374514B1
(en)
|
2003-12-10 |
2014-03-13 |
메다렉스, 인코포레이티드 |
Ip-10 antibodies and their uses
|
US7235641B2
(en)
|
2003-12-22 |
2007-06-26 |
Micromet Ag |
Bispecific antibodies
|
US7625549B2
(en)
|
2004-03-19 |
2009-12-01 |
Amgen Fremont Inc. |
Determining the risk of human anti-human antibodies in transgenic mice
|
MXPA06010673A
(en)
|
2004-03-19 |
2007-06-20 |
Amgen Inc |
Reducing the risk of human and anti-human antibodies through v gene manipulation.
|
KR101443473B1
(en)
|
2004-07-22 |
2014-09-22 |
에라스무스 유니버시티 메디컬 센터 로테르담 |
A method for the isolation of vh binding domains
|
FR2875239B1
(en)
|
2004-09-10 |
2007-07-20 |
Inst Necker Ass Loi De 1901 |
METHOD FOR THE ACCELERATION OF SOMATIC MUTATIONS AND ITS APPLICATION IN PROTEOMICS
|
WO2006029459A1
(en)
|
2004-09-13 |
2006-03-23 |
Evogenix, Inc |
Antibodies specific for hepatocellular carcinoma and other carcinomas and uses thereof
|
WO2006044492A2
(en)
|
2004-10-14 |
2006-04-27 |
Ingenious Targeting Laboratory, Inc. |
Methods for generating rat embryo-derived cell lines and genetic modification of rat genome
|
DK2767161T3
(en)
|
2004-10-19 |
2018-05-07 |
Regeneron Pharma |
Method of generating an animal homozygous for genetic modification
|
WO2006055704A2
(en)
|
2004-11-17 |
2006-05-26 |
Curagen Corporation |
Antibodies directed to ten-m proteins and uses thereof
|
WO2006068953A2
(en)
|
2004-12-21 |
2006-06-29 |
Astrazeneca Ab |
Antibodies directed to angiopoietin-2 and uses thereof
|
JP2008538912A
(en)
|
2005-04-29 |
2008-11-13 |
イナート・ファルマ |
Transgenic animal and method for producing recombinant antibody
|
CA2608481A1
(en)
|
2005-05-14 |
2006-11-23 |
Fudan University |
Piggybac as a tool for genetic manipulation and analysis in vertebrates
|
GB0510790D0
(en)
|
2005-05-26 |
2005-06-29 |
Syngenta Crop Protection Ag |
Anti-CD16 binding molecules
|
SG2014010029A
(en)
*
|
2005-08-19 |
2014-08-28 |
Abbott Lab |
Dual variable domain immunoglobin and uses thereof
|
EP1780272A1
(en)
*
|
2005-10-27 |
2007-05-02 |
GSF-Forschungszentrum für Umwelt und Gesundheit GmbH |
Method for enhancing somatic hypermutation, gene conversion and class switch recombination
|
GB0601513D0
(en)
|
2006-01-25 |
2006-03-08 |
Univ Erasmus Medical Ct |
Binding molecules 3
|
GB0601511D0
(en)
*
|
2006-01-25 |
2006-03-08 |
Univ Erasmus Medical Ct |
Binding Molecules 2
|
TWI404727B
(en)
*
|
2006-01-25 |
2013-08-11 |
Univ Erasmus Medical Ct |
Allelic exclusion
|
US7462759B2
(en)
|
2006-02-03 |
2008-12-09 |
Pioneer Hi-Bred International, Inc. |
Brittle stalk 2 gene family and related methods and uses
|
WO2007117410A2
(en)
|
2006-03-31 |
2007-10-18 |
Medarex, Inc. |
Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
|
MX2008014804A
(en)
|
2006-06-02 |
2009-01-27 |
Regeneron Pharma |
High affinity antibodies to human il-6 receptor.
|
CA2655344C
(en)
|
2006-06-27 |
2016-09-13 |
Vaxdesign Corporation |
Models for vaccine assessment
|
EP1878342A1
(en)
|
2006-07-13 |
2008-01-16 |
Institut Pasteur |
Immunodeficient mice transgenic for HLA class I and HLA class II molecules and their uses
|
WO2008022391A1
(en)
|
2006-08-22 |
2008-02-28 |
G2 Inflammation Pty Ltd |
Method for producing antibodies
|
CN101522716B
(en)
|
2006-10-02 |
2013-03-20 |
瑞泽恩制药公司 |
High affinity human antibodies to human IL-4 receptor
|
WO2008070367A2
(en)
|
2006-11-01 |
2008-06-12 |
Facet Biotech Corporation |
Mammalian cell-based immunoglobulin display libraries
|
US7556337B2
(en)
*
|
2006-11-02 |
2009-07-07 |
Xerox Corporation |
System and method for evaluating line formation in an ink jet imaging device to normalize print head driving voltages
|
RU2448979C2
(en)
|
2006-12-14 |
2012-04-27 |
Ридженерон Фармасьютикалз, Инк. |
Human antibodies to delta-like human ligand-4
|
GB0700194D0
(en)
|
2007-01-05 |
2007-02-14 |
Univ Edinburgh |
Humanisation of animals
|
EP1958957A1
(en)
|
2007-02-16 |
2008-08-20 |
NascaCell Technologies AG |
Polypeptide comprising a knottin protein moiety
|
BRPI0807952A2
(en)
*
|
2007-02-20 |
2014-06-10 |
Anaptysbio Inc |
Somatic Hypermutation Systems
|
MX2009008706A
(en)
|
2007-02-21 |
2009-09-14 |
Univ Massachusetts |
Human antibodies against hepatitis c virus (hcv) uses thereof.
|
JP5779350B2
(en)
|
2007-03-27 |
2015-09-16 |
シー レーン バイオテクノロジーズ, エルエルシー |
Constructs and libraries containing antibody surrogate light chain sequences
|
GB0706628D0
(en)
*
|
2007-04-04 |
2007-05-16 |
Univ Erasmus |
Germ-line manipulation 1
|
BRPI0812091A2
(en)
|
2007-05-25 |
2014-10-14 |
Symphogen As |
METHOD FOR MANUFACTURING A RECOMBINANT POLYCLONAL PROTEIN
|
CN101784664B
(en)
|
2007-06-01 |
2013-04-10 |
Omt公司 |
Compositions and methods for inhibiting endogenous immunoglobulin genes and producing transgenic human idiotype antibodies
|
WO2009013620A2
(en)
|
2007-06-11 |
2009-01-29 |
Erasmus University Medical Center Rotterdam |
Homologous recombination
|
AU2008275296A1
(en)
*
|
2007-07-06 |
2009-01-15 |
Sanofi Pasteur Vaxdesign Corporation |
Rapid generation of T cell-independent antibody responses to T cell-dependent antigens
|
US20090021474A1
(en)
|
2007-07-17 |
2009-01-22 |
Motorola, Inc. |
System and method for displaying status information of a multimedia broadcast receiver on an ambient device
|
WO2009018411A1
(en)
|
2007-07-31 |
2009-02-05 |
Regeneron Pharmaceuticals, Inc. |
Human antibodies to human cd20 and method of using thereof
|
EP2185718B1
(en)
*
|
2007-08-03 |
2017-10-04 |
MUSC Foundation For Research Development |
Human monoclonal antibodies and methods for producing the same
|
CA2695997C
(en)
|
2007-08-10 |
2016-11-22 |
Regeneron Pharmaceuticals, Inc. |
High affinity human antibodies to human nerve growth factor
|
EP2185692A4
(en)
|
2007-08-10 |
2012-05-02 |
Medarex Inc |
Hco32 and hco27 and related examples
|
CL2008003561A1
(en)
*
|
2007-11-30 |
2010-02-05 |
Glaxo Group Ltd |
Il-13 binding construct comprising at least one antibody single domain (dab) grafted onto a monoclonal antibody (mabdab); polynucleotide and host cell; procedure to prepare the construction; pharmaceutical composition comprising it and used to treat cancer or inflammatory diseases.
|
AU2008335178A1
(en)
|
2007-12-10 |
2009-06-18 |
Ablexis Llc |
Methods for sequential replacement of targeted region by homologous recombination
|
US8227577B2
(en)
|
2007-12-21 |
2012-07-24 |
Hoffman-La Roche Inc. |
Bivalent, bispecific antibodies
|
US20110107445A1
(en)
|
2008-03-26 |
2011-05-05 |
Iti Scotland Limited |
Efficient Insertion of DNA Into Embryonic Stem Cells
|
EP2271758B1
(en)
|
2008-04-14 |
2018-09-12 |
Innovative Targeting Solutions Inc. |
Sequence diversity generation in immunoglobulins
|
ES2828627T3
(en)
*
|
2008-04-25 |
2021-05-27 |
Kyowa Kirin Co Ltd |
Stable multivalent antibody
|
KR20110020860A
(en)
*
|
2008-05-23 |
2011-03-03 |
알리바 바이오파마수티컬스, 아이엔씨. |
Method of generating single vl domain antibodies in transgenic animals
|
AU2009263082C1
(en)
|
2008-06-27 |
2018-11-01 |
Merus N.V. |
Antibody producing non-human mammals
|
AU2009298458B2
(en)
|
2008-09-30 |
2015-10-08 |
Ablexis, Llc |
Non-human mammals for the production of chimeric antibodies
|
JO3672B1
(en)
|
2008-12-15 |
2020-08-27 |
Regeneron Pharma |
High Affinity Human Antibodies to PCSK9
|
AU2009329365B2
(en)
|
2008-12-18 |
2016-01-14 |
Roger Kingdon Craig |
Non-human transgenic animals expressing humanised antibodies and use thereof
|
WO2010091182A2
(en)
|
2009-02-04 |
2010-08-12 |
Molecular Innovations |
Methods for screening candidate agents for modulating prorenin and renin, assays for detecting prorenin, and antibodies used therein
|
CA2753287A1
(en)
*
|
2009-02-24 |
2010-09-02 |
Glaxo Group Limited |
Antigen-binding constructs
|
GB0905023D0
(en)
|
2009-03-24 |
2009-05-06 |
Univ Erasmus Medical Ct |
Binding molecules
|
CA2757178C
(en)
|
2009-04-03 |
2020-05-19 |
Medical Research Council |
Mutants of activation-induced cytidine deaminase (aid) and methods of use
|
WO2010132872A1
(en)
|
2009-05-15 |
2010-11-18 |
Novimmune S.A |
Combination therapies and methods using anti-cd3 modulating agents and anti-tnf antagonists
|
ES2729422T3
(en)
|
2009-05-28 |
2019-11-04 |
Glaxo Group Ltd |
Antigen binding proteins
|
EP2435479A1
(en)
|
2009-05-28 |
2012-04-04 |
Glaxo Group Limited |
Antigen-binding proteins
|
CA2764729C
(en)
|
2009-06-26 |
2019-04-02 |
Sea Lane Biotechnologies, Llc |
Expression of surrogate light chains
|
CN102471378B
(en)
|
2009-06-26 |
2014-04-02 |
瑞泽恩制药公司 |
Readily isolated bispecific antibodies with native immuneoglobulin format
|
US9445581B2
(en)
|
2012-03-28 |
2016-09-20 |
Kymab Limited |
Animal models and therapeutic molecules
|
US20120204278A1
(en)
|
2009-07-08 |
2012-08-09 |
Kymab Limited |
Animal models and therapeutic molecules
|
HUE055817T2
(en)
|
2009-07-08 |
2021-12-28 |
Kymab Ltd |
Animal models and therapeutic molecules
|
CA2768207C
(en)
*
|
2009-07-15 |
2019-12-03 |
Aimm Therapeutics B.V. |
Means and methods for producing high affinity antibodies
|
JO3182B1
(en)
|
2009-07-29 |
2018-03-08 |
Regeneron Pharma |
High Affinity Human Antibodies to Human Angiopoietin-2
|
JP5756802B2
(en)
|
2009-08-13 |
2015-07-29 |
クリスタル バイオサイエンス インク.Crystal Bioscience Inc. |
Transgenic animals producing antibodies with minimal CDRs
|
WO2011056864A1
(en)
*
|
2009-11-05 |
2011-05-12 |
Anaptysbio, Inc. |
Methods of generating improved antigen-binding agents using chain shuffling and optionally somatic hypermutation
|
JP5796846B2
(en)
|
2009-11-17 |
2015-10-21 |
エスエービー エルエルシー |
Human artificial chromosome vector
|
EP2509997B1
(en)
|
2009-12-07 |
2017-08-30 |
i2 Pharmaceuticals, Inc. |
Conjugates comprising an antibody surrogate scaffold with improved pharmacokinetic properties
|
LT2954779T
(en)
|
2009-12-10 |
2019-05-27 |
Regeneron Pharmaceuticals, Inc. |
Mice that make heavy chain antibodies
|
SI3095871T1
(en)
|
2010-02-08 |
2019-06-28 |
Regeneron Pharmaceuticals, Inc. |
Common light chain mouse
|
US20120021409A1
(en)
|
2010-02-08 |
2012-01-26 |
Regeneron Pharmaceuticals, Inc. |
Common Light Chain Mouse
|
AU2011256838B2
(en)
|
2010-05-17 |
2014-10-09 |
Sangamo Therapeutics, Inc. |
Novel DNA-binding proteins and uses thereof
|
CN103228130B
(en)
*
|
2010-06-17 |
2016-03-16 |
科马布有限公司 |
Animal model and treatment molecule
|
IL300712A
(en)
|
2010-06-22 |
2023-04-01 |
Regeneron Pharma |
Human lambda light chain mice
|
US8890233B2
(en)
*
|
2010-07-06 |
2014-11-18 |
Macronix International Co., Ltd. |
3D memory array with improved SSL and BL contact layout
|
EP2407487A1
(en)
*
|
2010-07-14 |
2012-01-18 |
F-Star Biotechnologische Forschungs - und Entwicklungsges. M.B.H. |
Multispecific modular antibody
|
DK2601298T3
(en)
|
2010-08-02 |
2017-02-27 |
Regeneron Pharma |
Mice generating binding proteins comprising VL domains
|
ES2537207T3
(en)
*
|
2010-08-16 |
2015-06-03 |
Novimmune S.A. |
Methods for the generation of multispecific and multivalent antibodies
|
EP2638155A1
(en)
*
|
2010-11-08 |
2013-09-18 |
Kymab Limited |
Cells & vertebrates for enhanced somatic hypermutation and class switch recombination
|
JO3375B1
(en)
|
2010-11-08 |
2019-03-13 |
Regeneron Pharma |
Human antibodies to human tnf-like ligand 1a (tl1a)
|
US20120195910A1
(en)
|
2010-12-22 |
2012-08-02 |
Genentech, Inc. |
Anti-pcsk9 antibodies and methods of use
|
PL2550363T3
(en)
|
2011-02-25 |
2015-05-29 |
Regeneron Pharma |
Adam6 mice
|
RS61946B1
(en)
|
2011-08-05 |
2021-07-30 |
Regeneron Pharma |
Humanized universal light chain mice
|
CA2846319A1
(en)
|
2011-09-19 |
2013-03-28 |
Kymab Limited |
Antibodies, variable domains & chains tailored for human use
|
WO2013041845A2
(en)
|
2011-09-19 |
2013-03-28 |
Kymab Limited |
Animals, repertoires & methods
|
WO2013045916A1
(en)
|
2011-09-26 |
2013-04-04 |
Kymab Limited |
Chimaeric surrogate light chains (slc) comprising human vpreb
|
EP3216871B1
(en)
|
2011-10-17 |
2021-12-22 |
Regeneron Pharmaceuticals, Inc. |
Restricted immunoglobulin heavy chain mice
|
US20130102031A1
(en)
|
2011-10-25 |
2013-04-25 |
Anaptysbio, Inc. |
Use of somatic hypermutation to create insertion and deletion mutations in vitro
|
GB2496375A
(en)
|
2011-10-28 |
2013-05-15 |
Kymab Ltd |
A non-human assay vertebrate comprising human antibody loci and human epitope knock-in, and uses thereof
|
US9253965B2
(en)
|
2012-03-28 |
2016-02-09 |
Kymab Limited |
Animal models and therapeutic molecules
|
GB201122047D0
(en)
|
2011-12-21 |
2012-02-01 |
Kymab Ltd |
Transgenic animals
|
PT2793567T
(en)
|
2011-12-20 |
2019-05-27 |
Regeneron Pharma |
Humanized light chain mice
|
ES2753774T3
(en)
|
2012-02-01 |
2020-04-14 |
Regeneron Pharma |
Humanized mice expressing heavy chains containing VL domains
|
WO2013130981A1
(en)
|
2012-03-02 |
2013-09-06 |
Regeneron Pharmaceuticals, Inc. |
Human antibodies to clostridium difficile toxins
|
KR20140136462A
(en)
|
2012-03-06 |
2014-11-28 |
리제너론 파마슈티칼스 인코포레이티드 |
Common light chain mouse
|
US9301510B2
(en)
|
2012-03-16 |
2016-04-05 |
Regeneron Pharmaceuticals, Inc. |
Mice that produce antigen-binding proteins with pH-dependent binding characteristics
|
WO2013144567A1
(en)
|
2012-03-28 |
2013-10-03 |
Kymab Limited |
Transgenic non-human vertebrate for the expression of class - switched, fully human, antibodies
|
GB2502127A
(en)
|
2012-05-17 |
2013-11-20 |
Kymab Ltd |
Multivalent antibodies and in vivo methods for their production
|
US10251377B2
(en)
|
2012-03-28 |
2019-04-09 |
Kymab Limited |
Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies
|
JO3820B1
(en)
|
2012-05-03 |
2021-01-31 |
Regeneron Pharma |
Human antibodies to fel d1 and methods of use thereof
|
PT2800811T
(en)
|
2012-05-25 |
2017-08-17 |
Univ California |
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
|
EP3597037B1
(en)
|
2012-06-12 |
2021-04-28 |
Regeneron Pharmaceuticals, Inc. |
Humanized non-human animals with restricted immunoglobulin heavy chain loci
|
MX2015007550A
(en)
|
2012-12-12 |
2017-02-02 |
Broad Inst Inc |
Delivery, engineering and optimization of systems, methods and compositions for sequence manipulation and therapeutic applications.
|
DK2840892T3
(en)
|
2013-02-20 |
2018-07-23 |
Regeneron Pharma |
Non-human animals with modified heavy chain immunoglobulin sequences
|
US9788534B2
(en)
|
2013-03-18 |
2017-10-17 |
Kymab Limited |
Animal models and therapeutic molecules
|
US20150033372A1
(en)
|
2013-05-01 |
2015-01-29 |
Kymab Limited |
Human VpreB & Chimaeric Surrogate Light Chains in Transgenic Non-Human Vertebrates
|
US9783618B2
(en)
|
2013-05-01 |
2017-10-10 |
Kymab Limited |
Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics
|
US9783593B2
(en)
|
2013-05-02 |
2017-10-10 |
Kymab Limited |
Antibodies, variable domains and chains tailored for human use
|
US11707056B2
(en)
|
2013-05-02 |
2023-07-25 |
Kymab Limited |
Animals, repertoires and methods
|
US20140331339A1
(en)
|
2013-05-03 |
2014-11-06 |
Kymab Limited |
Transgenic Non-Human Assay Vertebrates, Assays and Kits
|
US20140331344A1
(en)
|
2013-05-03 |
2014-11-06 |
Kymab Ltd. |
Transgenic Animals
|
TW201546284A
(en)
|
2013-10-01 |
2015-12-16 |
Kymab Ltd |
Animal models and therapeutic molecules
|
GB201710984D0
(en)
|
2017-07-07 |
2017-08-23 |
Kymab Ltd |
Cells, vertebrates, populations & methods
|